Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Medical transcription technology provider Abridge has emerged from stealth with seed and series A funding.

UC Investments has backed cancer cell therapy developer A2 Biotherapeutics, bringing the company's total funding to $136m.

Returning investor SoftBank Vision Fund came back for a round that valued the consumer product delivery platform at $3.9bn.

The Comcast, American Express and Amazon-backed grocery delivery service increased its valuation to $17.7bn in a round co-led by Valiant Peregrine Fund and D1 Capital Partners.

Oncology therapy developer A2 Biotherapeutics raised $71.5m from investors including Hartford HealthCare Endowment to take its funding to $136m altogether.

The customer service software provider pulled in series C funding from investors including Bonnier at a $3bn valuation.

Existing investors CBRE, Engie New Ventures and Evergy Ventures returned for a round that will help the energy efficiency retrofitter expand its product offering.

Applied Ventures contributed to a $50m round that pushed the total raised by the silicon photonics technology producer to $225m.